Skip to main content

Table 1 Profile of Herpes Zoster Cases by Varicella Vaccine Availability, BC 1997–2012

From: Increasing incidence associated with herpes zoster infection in British Columbia, Canada

 

Pre-licensure

Privately Funded

Publicly Funded

Overall

 

1997–1998

1999–2004

2005–2012

1997–2012

Age

 0–9

1577 (6.7 %)

4562 (5.9 %)

3619 (2.6 %)

9758 (4.1 %)

 10–19

1422 (6 %)

4649 (6.1 %)

6995 (5.1 %)

13066 (5.5 %)

 20–29

2073 (8.8 %)

6314 (8.2 %)

11706 (8.5 %)

20093 (8.4 %)

 30–39

2952 (12.5 %)

8743 (11.4 %)

13304 (9.7 %)

24999 (10.5 %)

 40–49

3098 (13.1 %)

10550 (13.7 %)

17872 (13 %)

31520 (13.2 %)

 50–59

3332 (14.1 %)

12544 (16.3 %)

25707 (18.7 %)

41583 (17.5 %)

 60–69

3397 (14.4 %)

11306 (14.7 %)

25270 (18.3 %)

39973 (16.8 %)

 70–79

3682 (15.6 %)

11049 (14.4 %)

19552 (14.2 %)

34283 (14.4 %)

 80+

2089 (8.8 %)

7149 (9.3 %)

13738 (10 %)

22976 (9.6 %)

 Unknown

12 (0.1 %)

24 (0 %)

8 (0 %)

44 (0 %)

 Mean (IQR)

49.6 (33–69)

50.2 (34–69)

53.2 (39–69)

51.9 (36–69)

Gender

 Male

10141 (42.9 %)

32247 (41.9 %)

56917 (41.3 %)

99305 (41.7 %)

 Female

13453 (56.9 %)

44579 (58 %)

80823 (58.7 %)

138855 (58.3 %)

 Unknown

40 (0.2 %)

64 (0.1 %)

31 (0 %)

135 (0.1 %)

Health Authority

 Interior

4040 (17.1 %)

13659 (17.8 %)

24215 (17.6 %)

41914 (17.6 %)

 Fraser

7470 (31.6 %)

24894 (32.4 %)

43316 (31.4 %)

75680 (31.8 %)

 Vancouver Coastal

5684 (24.1 %)

17632 (22.9 %)

33518 (24.3 %)

56834 (23.9 %)

 Island

4264 (18 %)

14231 (18.5 %)

26046 (18.9 %)

44541 (18.7 %)

 Northern

1174 (5.0 %)

3667 (4.8 %)

7902 (5.7 %)

12743 (5.4 %)

 Unknown

1002 (4.2 %)

2807 (3.7 %)

2774 (2 %)

6583 (2.8 %)

Immunosuppression Status (Any)

 Yes

905 (3.8 %)

3121 (4.1 %)

5500 (4.0 %)

9526 (4.0 %)

 No

22729 (96.2 %)

73769 (95.9 %)

132271 (96.0 %)

228769 (96.0 %)

Zoster Vaccinated

 Yes

NA

NA

516 (0.4 %)

516 (0.2 %)

 No

23634 (100 %)

76890 (100 %)

137255 (99.6 %)

237779 (99.8 %)